A new study from UC San Diego suggests that climate trauma — such as experiencing a devastating wildfire — can have lasting effects on cognitive function.
Researchers have developed a new drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential. The research highlights the new drug’s potential as a safer and more effective treatment option for conditions like schizophrenia.
UC San Diego School of Medicine professor Gene Yeo studies RNAs, which are some of the smallest molecules in biology, but have a huge impact on human health. According to Yeo, the RNA revolution is upon us, but it needs our help to continue.
With no approved therapies for spinal cord injuries, scientists are looking into the body’s healing mechanisms for clues on recovery. Researchers found that a gene named RYK inhibits wound healing, offering hope for new treatments for paralysis after spinal cord injury.
DNNs transform industries, but remain complex, posing risks. Prof. Lily Weng aims to develop a framework for understanding AI decisions.
Thanks to a new institutional user agreement with the DIII-D National Fusion Facility, UC San Diego personnel, including qualified graduate students, can now apply for access to the DIII-D tokamak facility even without being directly tied to a dedicated multi-year grant.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
